Natera

Performance

About Natera

Natera is a global leader in molecular diagnostics focused on cell-free DNA testing for oncology, women’s health, and organ health. The company develops cfDNA-based tests to inform personalized care decisions, including tumor profiling, hereditary cancer screening, and transplant assessments, with laboratories that are CAP/CLIA-certified and ISO 13485 certified. Its offerings span across oncology, prenatal and pregnancy genetics, and organ health, serving patients and clinicians worldwide. Natera emphasizes integrating test information into healthcare decisions and highlights extensive clinical validation and millions of patient studies in its portfolio.